Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 28, 2012

View Archived Issues

EE-TP shows promise for the treatment of MNGIE

New DNA supercoiling inhibitors for bacterial infections presented by Biota

Kalidex conducts phase I study of novel fluoroquinolone antibiotic

Teijin Pharma gains rights to investigational bronchial asthma drug

ASSURE trial of RVX-208 completes enrollment

Cannabis Science initiates European preclinical program for CS-TATI-1

Prozymex presents novel dipeptidyl peptidase 1 inhibitors

Chinese researchers synthesize new androgen receptor antagonists

Abbott launches Absorb bioresorbable vascular scaffold

Sanofi discloses several new agents for diabetes

Reckitt Benckiser to discontinue supply of Suboxone tablets in U.S.

Array BioPharma and Genentech report novel ERK inhibitors

Forest Laboratories submits NDA for levomilnacipran

Pharming completes phase III Ruconest study

FDA grants priority review status to sNDA for Amitiza

Bristol-Myers Squibb files application in Japan for Taxol for germ cell tumors

FDA acknowledges receipt of NDA resubmission for Eliquis

Pfizer and Acura Pharmaceuticals terminate license agreement

FDA accepts NDA for FF/VI for COPD

EMA recommends approval of ingenol mebutate for actinic keratosis

UCB's phase IIb study of olokizumab meets primary endpoint

Positive results reported from phase Ib trial of ACH-3102

BioMarin to start phase III program for PEG-PAL in 2013

Merck & Co. returns vernakalant rights

FDA approves Bayer's Stivarga for treatment of metastatic colorectal cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...